- Adds Data Reinforcing Efficacy and Safety of Long-Term Prophylactic Treatment in Adults, Adolescents and Children ... Business Wire (press release)
- The Zacks Investment Research Downgrades Bioverativ Inc (BIVV) to Strong Sell BangaloreWeeklyFull coverage
|
No comments:
Post a Comment